Cardinal Health, Inc. CAH

Set alert

Price alert · CAH

All alert types
254.33 USD +3.85 +1.54%

At close · Nov 2

254.33 0.00 0.00%

After hours · Nov 2, 6:36 PM ET

Bid
254.32 × 400
Ask
254.50 × 100
248.90 Day range 255.23
180.45 52-week range 259.84
YTD
+23.76%
1 year
+33.32%
Open
251.48
Prev close
250.48
Mkt cap
58.89B
Vol
1.90M
Avg vol
1.78M
EPS
7.34
P/E
34.65
Div yield
0.82%
More statistics
Low
248.90
High
255.23
Forward P/E
18.09
Beta
0.52
Short ratio
4.16
Inst. own
91.46%
Dividend
2.06
Ex-div date
Sep 30, 2026
Earnings
Nov 5, 2026
50-d avg
237.78
200-d avg
222.15
1y target
273.47

5Y chart

Chart tools
Interval

Events in this range
  • Dec 31, 2021Dividend: 0.491
  • Mar 31, 2022Dividend: 0.491
  • Jun 30, 2022Dividend: 0.496
  • Sep 30, 2022Dividend: 0.496
  • Dec 30, 2022Dividend: 0.4957
  • Jan 15, 2023Dividend: 0.496
  • Mar 31, 2023Dividend: 0.4957
  • Jun 30, 2023Dividend: 0.5006
  • Oct 2, 2023Dividend: 0.5006
  • Dec 29, 2023Dividend: 0.5006
  • Mar 28, 2024Dividend: 0.5006
  • Jun 30, 2024Dividend: 0.5056
  • Jul 1, 2024Dividend: 0.5056
  • Oct 1, 2024Dividend: 0.5056
  • Jan 2, 2025Dividend: 0.5056
  • Apr 1, 2025Dividend: 0.5056
  • Jul 1, 2025Dividend: 0.5107
  • Aug 12, 2025Earnings: 2.08; estimate 2.04; surprise 1.96%
  • Oct 1, 2025Dividend: 0.5107
  • Oct 30, 2025Earnings: 2.55; estimate 2.18; surprise 16.97%
  • Jan 2, 2026Dividend: 0.5107
  • Feb 5, 2026Earnings: 2.63; estimate 2.34; surprise 12.39%
  • Apr 1, 2026Dividend: 0.5107
  • Apr 30, 2026Earnings: 3.17; estimate 2.79; surprise 13.62%
  • Jul 1, 2026Dividend: 0.5158
  • Aug 11, 2026Earnings: 2.91; estimate 2.42; surprise 20.25%
  • Aug 13, 2026Rating: JP Morgan · Neutral → Neutral
  • Aug 13, 2026Rating: TD Cowen · Buy → Buy
  • Aug 19, 2026Rating: RBC Capital · — → Outperform
  • Oct 1, 2026Dividend: 0.5158
  • Oct 16, 2026Rating: UBS · Buy → Buy
  • Oct 20, 2026Rating: Mizuho · Outperform → Outperform
  • Oct 30, 2026Rating: Morgan Stanley · Overweight → Overweight
  • Nov 5, 2026Earnings: —; estimate 2.94; surprise —%
Signals (80)
NameDateAgo
MACD: Buy SignalOct 12, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago
SMA: BearishSep 14, 20261 month ago
MACD: Sell SignalSep 14, 20261 month ago
SMA: BullishAug 24, 20262 months ago
SMA: BearishAug 17, 20262 months ago
MACD: Buy SignalJun 22, 20264 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BullishJun 1, 20265 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BearishMar 9, 20267 months ago
MACD: Sell SignalMar 9, 20267 months ago
RSI: OverboughtFeb 16, 20268 months ago
RSI: OverboughtJan 26, 20269 months ago
SMA: BullishJan 12, 20269 months ago
RSI: OverboughtJan 12, 20269 months ago
SMA: BearishJan 5, 202610 months ago
MACD: Buy SignalOct 27, 20251 year ago
RSI: OverboughtOct 27, 20251 year ago
SMA: BullishSep 22, 20251 year ago

Newest 20 of 80.

Key statistics

Market cap
58.90B
Enterprise value
63.56B
Trailing P/E
35.18
Forward P/E
18.09
PEG ratio
1.25
Price / sales
0.23
Price / book
0.00
EPS (TTM)
7.23
Beta
0.52
Dividend yield
0.82%
Payout ratio
28.33%
Profit margin
0.67%
Revenue (TTM)
254.25B
Revenue growth
5.80%
Free cash flow
4.75B
Total cash
4.86B
Total debt
10.00B
Return on equity
0.00%
Shares outstanding
231.56M
Short % of float
3.32%
50-day average
237.78
200-day average
222.15

Financials — quick view

All financials
CAH Revenue — quarterly 63.67B
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
CAH Net income — quarterly 398.00M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
CAH EPS — quarterly 1.71
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026

Earnings

CAH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20262.94———
Aug 11, 2026Jun 30, 20262.422.91+0.49+20.25%
Apr 30, 2026Mar 31, 20262.793.17+0.38+13.62%
Feb 5, 2026Dec 31, 20252.342.63+0.29+12.39%
Oct 30, 2025Sep 30, 20252.182.55+0.37+16.97%
Aug 12, 2025Jun 30, 20252.042.08+0.04+1.96%

Upgrades / downgrades

CAH analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Morgan StanleymainOverweightOverweight
Oct 20, 2026MizuhomainOutperformOutperform
Oct 16, 2026UBSmainBuyBuy
Aug 19, 2026RBC Capitalinit—Outperform
Aug 13, 2026TD CowenmainBuyBuy
Aug 13, 2026JP MorganmainNeutralNeutral

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Sector
Healthcare
Industry
Medical Distribution
Country
United States

News

Your note

Sign in to keep a note on CAH — it syncs with the Stock Master app.

Insider holders

CAH insider holders
InsiderRelationLatest transactionDateShares held
ALT AARON E.Chief Financial OfficerSaleAug 17, 202620,495
HALL PATRICIA HEMINGWAYDirectorStock Award(Grant)Apr 14, 202628,645
HOLLAR JASON MChief Executive OfficerSaleAug 18, 2026190,603
JOHRI AKHILDirectorStock Award(Grant)Nov 4, 202522,868
KENNY GREGORY BDirectorStock Award(Grant)Nov 4, 202564,194
KILLEFER NANCYDirectorStock Award(Grant)Nov 4, 202527,624

Institution ownership

CAH institution ownership
Holder% heldSharesValueReported
Blackrock Inc.11.44%26,490,6336.74BJun 29, 2026
Vanguard Capital Management LLC6.60%15,292,1863.89BJun 29, 2026
Wellington Management Group, LLP6.42%14,860,2713.78BJun 29, 2026
Vanguard Portfolio Management LLC5.92%13,717,8943.49BJun 29, 2026
State Street Corporation5.17%11,967,1213.04BJun 29, 2026
Geode Capital Management, LLC2.80%6,472,8101.65BJun 29, 2026

Fund ownership

CAH fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.21%7,434,9021.89BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.62%6,067,5181.54BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.19%5,074,7081.29BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.34%3,099,179788.26MSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.31%3,040,204773.26MAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.24%2,870,270730.04MSep 29, 2026